FDSVX
Price
$74.87
Change
+$0.75 (+1.01%)
Updated
Jul 31 closing price
Net Assets
6.33B
RGEBX
Price
$80.73
Change
+$0.93 (+1.17%)
Updated
Jul 31 closing price
Net Assets
356.86B
Interact to see
Advertisement

FDSVX vs RGEBX

FDSVX vs RGEBX Comparison Chart in %
View a ticker or compare two or three
VS
FDSVX vs. RGEBX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FDSVX is a Buy and RGEBX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGEBX has more cash in the bank: 357B vs. FDSVX (6.33B). FDSVX pays higher dividends than RGEBX: FDSVX (0.16) vs RGEBX (0.00). FDSVX was incepted earlier than RGEBX: FDSVX (28 years) vs RGEBX (12 years). RGEBX (1.08) is less costly to investors than FDSVX (0.62). FDSVX is a more actively managed with annual turnover of: 60.00 vs. RGEBX (32.00). FDSVX has a lower initial minimum investment than RGEBX: FDSVX (0) vs RGEBX (250). FDSVX annual gain was more profitable for investors over the last year : 10.52 vs. RGEBX (0.66). FDSVX return over 5 years is better than : 25.94 vs. RGEBX (9.78).
FDSVXRGEBXFDSVX / RGEBX
Total Expense Ratio0.621.0857%
Annual Report Gross Expense Ratio0.621.0857%
Fund Existence28 years12 years-
Gain YTD7.2485.309137%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets6.33B357B2%
Annual Yield % from dividends0.160.00-
Returns for 1 year10.520.661,593%
Returns for 3 years45.1032.78138%
Returns for 5 years25.949.78265%
Returns for 10 years194.3090.83214%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TLSI4.54-0.02
-0.44%
TriSalus Life Sciences
UBS52.74-0.65
-1.22%
UBS Group AG
LNTH99.64-1.36
-1.35%
Lantheus Holdings
AVBP29.82-0.84
-2.74%
ArriVent BioPharma
DFNS27.68-57.30
-67.43%
T3 Defense Inc